199 related articles for article (PubMed ID: 19244130)
1. EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style.
Parri M; Taddei ML; Bianchini F; Calorini L; Chiarugi P
Cancer Res; 2009 Mar; 69(5):2072-81. PubMed ID: 19244130
[TBL] [Abstract][Full Text] [Related]
2. EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells.
Taddei ML; Parri M; Angelucci A; Bianchini F; Marconi C; Giannoni E; Raugei G; Bologna M; Calorini L; Chiarugi P
Mol Cancer Res; 2011 Feb; 9(2):149-60. PubMed ID: 21205836
[TBL] [Abstract][Full Text] [Related]
3. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.
Fang WB; Brantley-Sieders DM; Parker MA; Reith AD; Chen J
Oncogene; 2005 Nov; 24(53):7859-68. PubMed ID: 16103880
[TBL] [Abstract][Full Text] [Related]
4. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
[TBL] [Abstract][Full Text] [Related]
5. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.
Brantley-Sieders DM; Fang WB; Hicks DJ; Zhuang G; Shyr Y; Chen J
FASEB J; 2005 Nov; 19(13):1884-6. PubMed ID: 16166198
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of motility in metastasizing cells.
Yilmaz M; Christofori G
Mol Cancer Res; 2010 May; 8(5):629-42. PubMed ID: 20460404
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.
Matsuoka H; Tsubaki M; Yamazoe Y; Ogaki M; Satou T; Itoh T; Kusunoki T; Nishida S
Exp Cell Res; 2009 Jul; 315(12):2022-32. PubMed ID: 19393235
[TBL] [Abstract][Full Text] [Related]
8. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.
Taddei ML; Parri M; Angelucci A; Onnis B; Bianchini F; Giannoni E; Raugei G; Calorini L; Rucci N; Teti A; Bologna M; Chiarugi P
Am J Pathol; 2009 Apr; 174(4):1492-503. PubMed ID: 19264906
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness.
Galaup A; Cazes A; Le Jan S; Philippe J; Connault E; Le Coz E; Mekid H; Mir LM; Opolon P; Corvol P; Monnot C; Germain S
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18721-6. PubMed ID: 17130448
[TBL] [Abstract][Full Text] [Related]
10. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style.
Margheri F; Luciani C; Taddei ML; Giannoni E; Laurenzana A; Biagioni A; Chillà A; Chiarugi P; Fibbi G; Del Rosso M
Oncotarget; 2014 Mar; 5(6):1538-53. PubMed ID: 24681666
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
[TBL] [Abstract][Full Text] [Related]
12. Differential EphA2 epitope display on normal versus malignant cells.
Coffman KT; Hu M; Carles-Kinch K; Tice D; Donacki N; Munyon K; Kifle G; Woods R; Langermann S; Kiener PA; Kinch MS
Cancer Res; 2003 Nov; 63(22):7907-12. PubMed ID: 14633720
[TBL] [Abstract][Full Text] [Related]
13. Molecular plasticity of human melanoma cells.
Hendrix MJ; Seftor EA; Hess AR; Seftor RE
Oncogene; 2003 May; 22(20):3070-5. PubMed ID: 12789282
[TBL] [Abstract][Full Text] [Related]
14. [Vasculogenic mimicry--potential target for tumor therapy].
Yue WY; Chen ZP
Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of cancer cell invasion and plasticity.
Wolf K; Friedl P
Br J Dermatol; 2006 May; 154 Suppl 1():11-5. PubMed ID: 16712711
[TBL] [Abstract][Full Text] [Related]
16. Growth characteristics of murine B16 melanoma multicellular spheroids: a model for invasion and effects of doxorubicin treatments.
Kuwashima Y; Yamada T; Saio M; Takami T
Anticancer Res; 1993; 13(4):1215-7. PubMed ID: 8352546
[TBL] [Abstract][Full Text] [Related]
17. Collagenase effects on cancer cell invasiveness and motility.
Maslow DE
Invasion Metastasis; 1987; 7(5):297-310. PubMed ID: 2824398
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces.
Rösel D; Brábek J; Tolde O; Mierke CT; Zitterbart DP; Raupach C; Bicanová K; Kollmannsberger P; Panková D; Vesely P; Folk P; Fabry B
Mol Cancer Res; 2008 Sep; 6(9):1410-20. PubMed ID: 18819929
[TBL] [Abstract][Full Text] [Related]
19. Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F(2)alpha.
Tsai CS; Luo SF; Ning CC; Lin CL; Jiang MC; Liao CF
Biomed Pharmacother; 2009 Aug; 63(7):522-7. PubMed ID: 18849138
[TBL] [Abstract][Full Text] [Related]
20. A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.
Jackson D; Gooya J; Mao S; Kinneer K; Xu L; Camara M; Fazenbaker C; Fleming R; Swamynathan S; Meyer D; Senter PD; Gao C; Wu H; Kinch M; Coats S; Kiener PA; Tice DA
Cancer Res; 2008 Nov; 68(22):9367-74. PubMed ID: 19010911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
